Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-07

FDA Approved: OLOPATADINE — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved an original ANDA for olopatadine from Somerset Therapeutics, LLC, authorizing a generic ophthalmic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE (OLOPATADINE)

Snippet

ORIG AP for OLOPATADINE (OLOPATADINE)